Neural transplants for parkinson's disease: what are the issues? - Roger A. Barker (Poiesis Prax., 2006)

Automated quantification of caudate atrophy by local registration of serial MRI: Evaluation and application in Huntington's disease. - Nicola Z. Hobbs; Susie M. D. Henley; Edward J. Wild; Kelvin K. Leung; Chris Frost 001; Roger A. Barker; Rachael I. Scahill; Josephine Barnes; Sarah J. Tabrizi; Nick C. Fox (NeuroImage, 2009)

Top-Down Attentional Control in Parkinson's Disease: Salient Considerations. - Roshan Cools; Robert Rogers; Roger A. Barker; Trevor W. Robbins (J. Cogn. Neurosci., 2010)

Dynamic causal modelling of effective connectivity from fMRI: Are results reproducible and sensitive to Parkinson's disease and its treatment? - James B. Rowe; Laura E. Hughes; Roger A. Barker; Adrian M. Owen (NeuroImage, 2010)

Habitual versus Goal-directed Action Control in Parkinson Disease. - Sanne de Wit; Roger A. Barker; Anthony D. Dickinson; Roshan Cools (J. Cogn. Neurosci., 2011)

White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function. - Charlotte Rae; Marta Morgado Correia; Ellemarije Altena; Laura E. Hughes; Roger A. Barker; James B. Rowe (NeuroImage, 2012)

Noradrenergic deficits contribute to apathy in Parkinson's disease through the precision of expected outcomes. - Frank H. Hezemans; Noham Wolpe; Claire O'Callaghan; Rong Ye; Catarina Rua; P. Simon Jones; Alexander G. Murley; Negin Holland; Ralf Regenthal; Kamen A. Tsvetanov; Roger A. Barker; Caroline H. Williams-Gray; et al. (PLoS Comput. Biol., 2022)